Cloxacillin
Cloxapen, Tegopen (cloxacillin) is a small molecule pharmaceutical. Cloxacillin was first approved as Tegopen on 1982-01-01. It is used to treat bacterial pneumonia, cellulitis, joint diseases, osteomyelitis, and postoperative complications amongst others in the USA.
Download report
Favorite
Commercial
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Cloxacillin sodium
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
TEGOPEN | Bristol Myers Squibb | N-050192 DISCN | 1982-01-01 | 1 products |
Hide discontinued
Labels
FDA
EMA
No data
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
bacterial pneumonia | EFO_1001272 | D018410 | J15.9 |
cellulitis | EFO_0003035 | D002481 | L03.90 |
joint diseases | HP_0003040 | D007592 | M12.9 |
osteomyelitis | EFO_0003102 | D010019 | M86 |
postoperative complications | — | D011183 | — |
staphylococcal skin infections | EFO_1001849 | D013207 | L00 |
urinary tract infections | EFO_0003103 | D014552 | N39.0 |
wound infection | — | D014946 | — |
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
HCPCS
No data
Clinical
Clinical Trials
2 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Migraine disorders | D008881 | EFO_0003821 | G43 | — | — | 1 | — | — | 1 |
Headache | D006261 | HP_0002315 | R51 | — | — | 1 | — | — | 1 |
Migraine without aura | D020326 | EFO_0005296 | G43.0 | — | — | 1 | — | — | 1 |
Migraine with aura | D020325 | EFO_0005295 | G43.1 | — | — | 1 | — | — | 1 |
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | — | — | 1 | 1 |
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name | CLOXACILLIN |
INN | cloxacillin |
Description | Cloxacillin is a semisynthetic penicillin antibiotic carrying a 3-(2-chlorophenyl)-5-methylisoxazole-4-carboxamido group at position 6. It has a role as an antibacterial agent and an antibacterial drug. It is a semisynthetic derivative, a penicillin allergen and a penicillin. It is functionally related to an oxacillin. It is a conjugate acid of a cloxacillin(1-). |
Classification | Small molecule |
Drug class | penicillins |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | Cc1onc(-c2ccccc2Cl)c1C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)O)C(C)(C)S[C@H]12 |
Identifiers
PDB | — |
CAS-ID | 61-72-3 |
RxCUI | 2625 |
ChEMBL ID | CHEMBL891 |
ChEBI ID | 49566 |
PubChem CID | 6098 |
DrugBank | DB01147 |
UNII ID | O6X5QGC2VB (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 6,752 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
2,150 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more